Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.
Reitz
Andre
A
Neuro-Urology, Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland. areitz@balgrist.unizh.ch
Schurch
Brigitte
B
D000328:Adult; D001905:Botulinum Toxins / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007267:Injections; D008666:Metalloendopeptidases / Q000008:administration & dosage*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000503:physiopathology
C096323:rimabotulinumtoxinB; D008666:Metalloendopeptidases; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A